Navigation Links
QMed, Inc. Retains Lazard Middle Market
Date:11/12/2007

EATONTOWN, N.J., Nov. 12 /PRNewswire-FirstCall/ -- QMed, Inc., (Nasdaq: QMED) today announced that it has retained Lazard Middle Market to assist it in exploring strategic alternatives. Lazard Middle Market is the middle market financial advisory business of Lazard. Barry Freeman and Ryan Stewart with Lazard Middle Market Healthcare Services group will manage the process and will report to QMed's Board of Directors.

Additionally, Bruce Wesson, QMed's Chairman, has resigned from the board. "We thank Bruce for all his years of service and dedication to the Company," said Jane Murray, QMed's President and Chief Executive Officer. QMed's Board of Directors continues to consist of Jane Murray and three outside directors.

About QMed, Inc.

QMed has developed evidence-based clinical information management systems for use by health plan customers. The QMed systems incorporate Disease Management services to patients and decision support to physicians. The Company's subsidiaries have specialized in serving high-risk populations of Medicare beneficiaries.

Except for historical information contained herein, matters discussed in this news release are forward-looking statements that involve risks and uncertainties. They include but are not limited to those relating to the timely implementation of programs, the impact of business and operational conditions, competitive product introductions, acceptance and pricing, and those risks detailed in the Company's filings with the Securities and Exchange Commission (SEC). Actual results may differ materially from any forward-looking statements due to these risks and uncertainties.

For more information contact:

QMed, Inc.:

Jane Murray (732) 544-5544

Lazard Middle Market:

Barry Freeman (312) 928-0760 x17

bfreeman@agio.com

Ryan Stewart (612) 803-2215

rstewart@agio.com


'/>"/>
SOURCE QMed, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. QMed, Inc. Comments on Estimated 3rd Quarter Results & Medical Expense Ratio; Sets 2008 Revenue Guidance for Medicare SNPs at $88-95 Million
2. QMed, Inc. Extends Agreement & Receives $550,000 Performance Bonus
3. QMed, Inc. Reports Third Quarter Results
4. Assured Pharmacy Retains Empire Financial Group
5. Sunnylife Global Retains The Blaine Group For Investor Relations, Financial Public Relations
6. Bioponic Phytoceuticals Retains OTC Financial Network for Investor Relations
7. MaxLife Fund Corp. retains the Law firm, Anslow & Jaclin, LLP of Manalapan, N.J., to review MaxLife Fund Corp. options to be listed on the NASDAQ Capital Market
8. Genesis Technology Group Retains CCG Elite
9. The Ultimate Stress Reliever, SpaCapsule(R), the Capsule that Takes You on a Rejuvenating Journey to the Spa, Retains TransMedia Group for Soothing PR
10. Monogram Biosciences to Present at The Lazard Capital Markets Fourth Annual Healthcare Conference
11. Scientists puzzled by severe allergic reaction to cancer drug in the middle Southern US
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... ... People are starting to accept that hearing aids can be helpful and ... it had when great-grandpa wore his hearing aids years ago,” said Dr. Maura Marks, ... American Speaker Series (NASS) segment. “He probably wore an iPod-size hearing aid on ...
(Date:4/28/2017)... Pensacola, FL (PRWEB) , ... April 28, 2017 ... ... Tampa, Florida are conducting a pilot study of ActiGraph’s CentrePoint Data ... ActiGraph is a leading provider of clinical-grade wearable activity and sleep monitoring solutions ...
(Date:4/28/2017)... ... April 28, 2017 , ... Woolsy Corporation Limited, a ... its Nova Skin Sciences division, recently announced the launch of Allumière Antiaging Cream, ... power of an anti-aging concentrate. , Anogeissus Leiocarpa Bark Extract and ...
(Date:4/28/2017)... ... April 28, 2017 , ... Semrock’s ... is the premier online modeling resource for fluorescence microscopists and optical system designers, ... during last 5 years spanning the globe, SearchLight has become a tremendously popular ...
(Date:4/27/2017)... DC (PRWEB) , ... April 27, 2017 , ... ... Behavioral Economics Insights in Incentives, Rewards, and Recognition: A Nudge Guide," a groundbreaking ... recognition (IRR) field. Offering practical takeaways to apply immediately to IRR programs, the ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... consumer product development program, based on its proprietary ... Investigative Dermatology (SID) 76 th Annual Meeting.  ... the sciences relevant to skin health and disease ...
(Date:4/20/2017)... April 20, 2017   ZappRx, Inc ., a digital ... prescribing process, today announced it closed $25 million in Series ... capital firm based in Seattle that ... Partners . The Series B round included participation from ... 2014, and GV (formerly Google Ventures). As part ...
(Date:4/20/2017)... 2017 Eyevensys, a private biotechnology ... gene expression technology that enables the safe, local, sustained ... a wide range of ophthalmic diseases, announces it has ... Regulatory Agency (MHRA) to advance its technology into clinical ... The ...
Breaking Medicine Technology: